Position in ALKS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$13,100,000
+$4,260,000 QoQ
Shares Held
250,000
0.0% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#78
of 424 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026C WorldWide Group Holding A/S holds $34,167,500 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (38.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
125,000 | $21,067,500 | |
| 2 | ALKS |
Alkermes plc.
This page
|
250,000 | $13,100,000 |
All Filings in ALKS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,100,000 | 250,000 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $8,840,000 | 250,000 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $6,995,000 | 250,000 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $7,500,000 | 250,000 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $7,152,500 | 250,000 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $8,255,000 | 250,000 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $7,190,000 | 250,000 | Shares | Defined | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||